Pacer Advisors, Inc. Immunity Bio, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.82 - $9.15 $17,443 - $33,113	-3,619 Reduced 59.36%	2,478 $15,000
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $19,693 - $37,618	6,097 New	6,097 $32,000
Q2 2021 Jul 21, 2021	SELL	$13.41 - $22.4 $21,697 - $36,243	-1,618 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$12.83 - $42.25 $20,758 - $68,360	1,618 New	1,618 $38,000

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.